What Research Solutions (RSSS) Said on Its Q1 Earnings Call

Research Solutions logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Fiscal Q1 revenue declined 3% year over year to $11.9 million as lower document-delivery orders and consumer ARR offset growth in corporate subscriptions. Net income edged up to $765,000, while adjusted EBITDA fell to $1 million from $1.5 million.
  • AI adoption and business ARR are growing: B2B ARR rose 11.5% to about $16.5 million, and AI-related B2B ARR increased 38% to $1.1 million. After the quarter, the company signed a one-year, $1 million ARR expansion deal and reported a pipeline well over $5 million in ARR.
  • Management said the delayed large contract will weigh on expected full-year revenue and adjusted EBITDA, while customer churn remains a major challenge despite improving from a year earlier. Research Solutions ended the quarter with $12.6 million in cash and no long-term debt.
  • Five stocks to consider instead of Research Solutions.

Research Solutions NASDAQ: RSSS reported lower revenue for its fiscal 2027 first quarter as weakness in document delivery and its consumer business offset growth in corporate subscriptions. Management said demand for its artificial intelligence research tools is growing, including a $1 million annual recurring revenue deal signed after the quarter ended.

Revenue for the quarter ended September 30, 2026, fell to $11.9 million from $12.3 million a year earlier. Net income rose to $765,000, or $0.02 per diluted share, from $749,000, also $0.02 per share, in the prior-year period.

Chairman and Chief Executive Officer Roy W. Olivier said customer adoption and publisher participation in the company’s AI tools improved during the quarter, although customer churn remained higher than management wants. Chief Financial Officer Dave Kutil said the timing of the large deal would affect revenue and adjusted earnings, and that full-year adjusted EBITDA would likely be somewhat lower than management discussed on its previous call.

Subscription Growth Offsets Some Transaction Weakness

Platform subscription revenue rose 3.7% to $5.3 million, helped by new business customers and sales to existing customers. That growth was partly offset by a decline in consumer annual recurring revenue, or ARR.

Total ARR reached $22.5 million, up 5.7% from a year earlier. Business-to-business ARR rose 11.5% to approximately $16.5 million, while normalized ARR from Scite’s consumer subscribers was approximately $6 million. During the quarter, net B2B ARR increased about $257,000, while normalized consumer ARR fell about $299,000.

Transaction revenue declined approximately 8% to $6.6 million, primarily because of lower paid order volume. Olivier said the document delivery business continued to face a year-over-year headwind from lost customers, while the causes of some other weakness were less clear. He said AI could be a factor, as could normal fluctuations in customers’ research cycles.

The company added 22 net new platform deployments, bringing the total to 1,298. Its active customer count rose to 1,360 from 1,326 a year earlier, as academic customer growth more than offset a decline in corporate customers.

AI Usage and Larger Deals

Chief Strategy Officer Josh Nicholson said the cumulative number of research papers read through the company by AI assistants had surpassed 33 million since February, more than double the 16 million reported at the previous call in September. The company’s tools are available through assistants including Claude, ChatGPT and Microsoft Copilot.

Forty-nine business customers had AI access written into their contracts, up from 42 in the prior quarter, Nicholson said. AI-related B2B ARR was approximately $1.1 million at quarter-end, up 38% from the end of fiscal 2026.

Olivier said the recently signed $1 million ARR agreement is a one-year deal with potential upside in years two and three. He described it as a material expansion by a longtime Article Galaxy customer and said the company has other large opportunities in its pipeline. The pipeline was “well over $5 million in ARR,” he said, though he cautioned that large deals can take longer to close.

Nicholson also said researchers at more than 15 corporate customers completed hundreds of article and rights orders through AI assistants and agents in October. Such purchases remain a small share of total orders, he said.

Margins Improve, but Adjusted EBITDA Falls

Consolidated gross margin expanded to 53.6% from 50.6% a year earlier, reflecting a greater contribution from the higher-margin platform business and improved transaction margins. Gross profit rose 2.5% to $6.4 million despite the revenue decline.

Adjusted EBITDA fell to $1 million from $1.5 million, as higher general and administrative costs and technology investment outweighed gains from gross profit and lower sales and marketing expenses. Olivier said adjusted EBITDA would have been about $1.5 million excluding one-time items, primarily severance and legal costs.

Operating cash flow was $1.2 million, compared with approximately $1.1 million a year earlier. The company ended the quarter with $12.6 million in cash and no long-term debt, after making $1.2 million in cash payments tied to its Scite acquisition earnout.

Outlook and Churn

Kutil said the large contract closed later than anticipated, affecting expected full-year revenue and adjusted EBITDA, though he expects the adjusted EBITDA run rate to continue increasing. He also said consumer business trends had improved early in the second quarter, while noting that the business is cyclical and winter break can disrupt momentum.

On customer retention, Kutil said quarterly churn had been about $300,000 over the past three quarters, down roughly 30% from around a year earlier following efforts to address it. Olivier nevertheless called churn the company’s “biggest pain point” and said it continues to offset too much of the growth from sales to existing customers.

About Research Solutions (NASDAQ:RSSS)

Research Solutions, Inc. provides cloud-based tools that help researchers find, access and manage scientific, technical and medical information. Its services are used by organizations including businesses, universities and research institutions. The company's Article Galaxy platform supports literature discovery, document delivery and research workflows, connecting users with scholarly content from publishers. Research Solutions also offers Scite, an AI-powered research tool that helps users evaluate scientific publications and see how other studies have cited them.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Research Solutions Right Now?

Before you consider Research Solutions, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Research Solutions wasn't on the list.

While Research Solutions currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines